Arab News, Saturday, Aug 20, 2022 | Muharram 22, 1444
Saudi Jamjoom Pharma to invest $52m in Uzbekistan as it eyes Central Asia expansion
Saudi Arabia: Saudi Arabian
pharmaceutical firm Jamjoom Pharma has signed an agreement to invest over $52
million in Uzbekistan, as the firm continues its expansion into the Central
Asian region, the company's vice chairman said.
In an exclusive interaction with Arab News on the
sidelines of the fourth meeting of the Saudi-Uzbeki Business Council in Jeddah,
Mahmoud Jamjoom, vice chairman of Jamjoom Pharma, said that launching its
operations in Uzbekistan is a gateway to the region.
“Already, we are in 30-plus countries. Now, we are
trying to focus on this area (Central Asia). We are covering Uzbekistan,
Afghanistan, and Turkmenistan. So, this will be the gate to cover the area,”
said Jamjoom.
He said that the operations in Uzbekistan will
begin soon once they receive approvals from regulators.
“We will be submitting the files. We will then
start presenting the product in Uzbekistan. And step by step, we will have local
manufacturing,” added the vice chairman.